{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:50:08Z","timestamp":1791319808985,"version":"4.3.1"},"reference-count":229,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374373"],"award-info":[{"award-number":["82374373"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82374218"],"award-info":[{"award-number":["82374218"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seminarsinnephrology.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Nephrology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.semnephrol.2026.151723","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:32:03Z","timestamp":1790890323000},"page":"151723","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Abelmoschus manihot in Chronic Kidney Disease: Evidence-Based Therapeutics and Mechanistic Insights"],"prefix":"10.1016","author":[{"given":"Sifan","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semnephrol.2026.151723_bib0001","unstructured":"Chinese Pharmacopoeia Commission. Pharmacopoeia of the People's Republic of China, 2022, China Medical Science Press; Beijing, English version, 2020 ed."},{"key":"10.1016\/j.semnephrol.2026.151723_bib0002","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fphar.2020.01068","article-title":"Traditional uses, chemical constituents, biological properties, clinical settings, and toxicities of Abelmoschus manihot L.: a comprehensive review","volume":"11","author":"Luan","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0003","unstructured":"Wu ZY, Raven PH, Hong DY, Flora of China. Science Press; Beijing, 2007;12:283\u2013284, Missouri Botanical Garden Press, St. Louis."},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0004","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1053\/j.ajkd.2014.01.431","article-title":"Efficacy and safety of Abelmoschus manihot for primary glomerular disease: a prospective, multicenter randomized controlled clinical trial","volume":"64","author":"Zhang","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2020.153231","article-title":"Efficacy and safety of Abelmoschus manihot for IgA nephropathy: a multicenter randomized clinical trial","volume":"76","author":"Li","year":"2020","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151723_bib0006","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.2337\/dc22-0607","article-title":"Efficacy of combined Abelmoschus manihot and irbesartan for reduction of albuminuria in patients with type 2 diabetes and diabetic kidney disease: a multicenter randomized double-blind parallel controlled clinical trial","volume":"45","author":"Zhao","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0007","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154011","article-title":"Efficacy and safety of Abelmoschus manihot in treating chronic kidney diseases: a multicentre, open-label and single-arm clinical trial","volume":"99","author":"Sun","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0008","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jchromb.2017.05.020","article-title":"Dynamic changes of flavonoids in Abelmoschus manihot different organs at different growth periods by UPLC-MS\/MS","volume":"1059","author":"Pan","year":"2017","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0009","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2024.116558","article-title":"Qualitative and quantitative analysis of major components in Abelmoschus manihot flowers treated with different drying methods using UHPLC Q-Exactive MS and HPLC-PDA","volume":"253","author":"Zhu","year":"2025","journal-title":"J Pharm Biomed Anal"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151723_bib0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e22017","article-title":"The pharmacological mechanism of Abelmoschus manihot in the treatment of chronic kidney disease","volume":"9","author":"Wei","year":"2023","journal-title":"Heliyon"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0011","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10600-018-2317-z","article-title":"Flavonoids from flowers of Abelmoschus manihot","volume":"54","author":"Yang","year":"2018","journal-title":"Chem Nat Compd"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0012","article-title":"The multiple biological activities of hyperoside: from molecular mechanisms to therapeutic perspectives in neoplastic and non-neoplastic diseases","volume":"16","author":"Zhang","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0013","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.cbi.2018.08.013","article-title":"Hyperoside suppresses tumor necrosis factor \u03b1-mediated vascular inflammatory responses by downregulating mitogen-activated protein kinases and nuclear factor-\u03baB signaling","volume":"294","author":"Jang","year":"2018","journal-title":"Chem Biol Interact"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0014","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11596-018-1869-2","article-title":"Hyperoside suppresses lipopolysaccharide-induced inflammation and apoptosis in human umbilical vein endothelial cells","volume":"38","author":"Zhou","year":"2018","journal-title":"Curr Med Sci"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.fct.2023.113601","article-title":"Hyperoside attenuates CD-induced kidney injury via inhibiting NLRP3 inflammasome activation and ROS\/MAPK\/NF-\u03baB signaling pathway in vivo and in vitro","volume":"172","author":"Li","year":"2023","journal-title":"Food Chem Toxicol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0016","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.freeradbiomed.2012.12.023","article-title":"The effect of hyperoside on the functional recovery of the ischemic\/reperfused isolated rat heart: potential involvement of the extracellular signal-regulated kinase 1\/2 signaling pathway","volume":"57","author":"Li","year":"2013","journal-title":"Free Radic Biol Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0017","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.apjtm.2015.12.001","article-title":"Protective effect of hyperoside on cardiac ischemia reperfusion injury through inhibition of er stress and activation of Nrf2 signaling","volume":"9","author":"Hou","year":"2016","journal-title":"Asian Pac J Trop Med"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0018","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/5445548","article-title":"Hyperoside ameliorates renal tubular oxidative damage and calcium oxalate deposition in rats through AMPK\/Nrf2 signaling axis","volume":"2023","author":"Tian","year":"2023","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153138","article-title":"Hyperoside suppresses hypoxia-induced A549 survival and proliferation through ferrous accumulation via AMPK\/HO-1 axis","volume":"67","author":"Chen","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0020","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/3997190","article-title":"Pharmacological activity of quercetin: an updated review","volume":"2022","author":"Wang","year":"2022","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0021","article-title":"Protective effect of quercetin on kidney diseases: from chemistry to herbal medicines","volume":"13","author":"Chen","year":"2022","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0022","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1142\/S0192415X23500465","article-title":"Quercetin ameliorates diabetic kidney injury by inhibiting ferroptosis via activating Nrf2\/HO-1 signaling pathway","volume":"51","author":"Feng","year":"2023","journal-title":"Am J Chin Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0023","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.clnu.2011.01.010","article-title":"Quercetin reduces markers of oxidative stress and inflammation in sarcoidosis","volume":"30","author":"Boots","year":"2011","journal-title":"Clin Nutr"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151723_bib0024","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1093\/jn\/137.11.2405","article-title":"Quercetin reduces blood pressure in hypertensive subjects","volume":"137","author":"Edwards","year":"2007","journal-title":"J Nutr"},{"issue":"9","key":"10.1016\/j.semnephrol.2026.151723_bib0025","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1249\/mss.0b013e318076b566","article-title":"Quercetin reduces illness but not immune perturbations after intensive exercise","volume":"39","author":"Nieman","year":"2007","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0026","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.fct.2014.03.018","article-title":"Isoquercitrin: pharmacology, toxicology, and metabolism","volume":"68","author":"Valentov\u00e1","year":"2014","journal-title":"Food Chem Toxicol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0027","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1017\/S0007114519002137","article-title":"Enzymatically modified isoquercitrin improves endothelial function in volunteers at risk of cardiovascular disease","volume":"123","author":"Bondonno","year":"2020","journal-title":"Br J Nutr"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0028","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/jn\/132.4.630","article-title":"Quercetin-3-glucoside is transported by the glucose carrier SGLT1 across the brush border membrane of rat small intestine","volume":"132","author":"Wolffram","year":"2002","journal-title":"J Nutr"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0029","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.ejphar.2016.08.006","article-title":"Nitric oxide and Kir6.1 potassium channel mediate isoquercitrin-induced endothelium-dependent and independent vasodilation in the mesenteric arterial bed of rats","volume":"788","author":"Gasparotto Junior","year":"2016","journal-title":"Eur J Pharmacol"},{"issue":"51","key":"10.1016\/j.semnephrol.2026.151723_bib0030","doi-asserted-by":"crossref","first-page":"35456","DOI":"10.1074\/jbc.M114.621599","article-title":"Isoquercitrin suppresses colon cancer cell growth in vitro by targeting the Wnt\/\u03b2-catenin signaling pathway","volume":"289","author":"Amado","year":"2014","journal-title":"J Biol Chem"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0031","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/1440-1681.12705","article-title":"Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation","volume":"44","author":"Zhang","year":"2017","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151723_bib0032","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1055\/s-0029-1185317","article-title":"Metabolism of hibifolin by human intestinal bacteria","volume":"75","author":"Xu","year":"2009","journal-title":"Planta Med"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0033","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.compbiolchem.2016.08.005","article-title":"Inhibitory activity of hibifolin on adenosine deaminase\u2014experimental and molecular modeling study","volume":"64","author":"Arun","year":"2016","journal-title":"Comput Biol Chem"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0034","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.neulet.2009.06.010","article-title":"Hibifolin, a flavonol glycoside, prevents beta-amyloid-induced neurotoxicity in cultured cortical neurons","volume":"461","author":"Zhu","year":"2009","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0035","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.00950-22","article-title":"Hibifolin, a natural sortase A inhibitor, attenuates the pathogenicity of Staphylococcus aureus and enhances the antibacterial activity of cefotaxime","volume":"10","author":"Song","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0036","first-page":"284","article-title":"Research progress in natural sources, biosynthesis and metabolism regulation of rutin in plant-derived food materials","volume":"46","author":"Zhou","year":"2025","journal-title":"Food Sci"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0037","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.jsps.2016.04.025","article-title":"The pharmacological potential of rutin","volume":"25","author":"Ganeshpurkar","year":"2017","journal-title":"Saudi Pharm J"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0038","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.phytol.2021.10.006","article-title":"Health benefits and limitations of rutin\u2014a natural flavonoid with high nutraceutical value","volume":"46","author":"Semwal","year":"2021","journal-title":"Phytochem Lett"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0039","first-page":"907","article-title":"Rutin revisited: a comprehensive review of its pharmacological properties, analytical advances, and novel formulation strategies","volume":"25","author":"Jayaraman","year":"2025"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151723_bib0040","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.3390\/antiox10111696","article-title":"A comparative study of rutin and rutin glycoside: antioxidant activity, anti-inflammatory effect, effect on platelet aggregation and blood coagulation","volume":"10","author":"Choi","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106163","article-title":"Rutin ameliorates inflammation and improves metabolic function: a comprehensive analysis of scientific literature","volume":"178","author":"Muvhulawa","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2025.151833","article-title":"Rutin isolated from Acalypha indica L.: a comprehensive analysis of its antibacterial and anticancer activities","volume":"765","author":"Chekuri","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0043","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ptr.7611","volume":"37","author":"Bazyar","year":"2023","journal-title":"Phytother Res"},{"issue":"5-6","key":"10.1016\/j.semnephrol.2026.151723_bib0044","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1515\/znc-2011-5-603","article-title":"Melanin biosynthesis inhibitory and antioxidant activities of quercetin-3\u2032-O-beta-D-glucoside isolated from Allium cepa","volume":"66","author":"Arung","year":"2011","journal-title":"Z Naturforsch C J Biosci"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0045","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0031-9422(03)00507-7","article-title":"Cloning and regiospecificity studies of two flavonoid glucosyltransferases from Allium cepa","volume":"64","author":"Kramer","year":"2003","journal-title":"Phytochemistry"},{"issue":"15","key":"10.1016\/j.semnephrol.2026.151723_bib0046","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1016\/j.phytochem.2006.06.026","article-title":"Cloning and functional characterisation of two regioselective flavonoid glucosyltransferases from Beta vulgaris","volume":"67","author":"Isayenkova","year":"2006","journal-title":"Phytochemistry"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0047","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/S0031-9422(00)85534-X","article-title":"Flavonol glycosides from leaves of Strychnos variabilis","volume":"25","author":"Brasseur","year":"1986","journal-title":"Phytochemistry"},{"issue":"14","key":"10.1016\/j.semnephrol.2026.151723_bib0048","first-page":"1816","article-title":"Chemical constituents and antitumor activity on leukemia K562 cell of Leonurus heterophyllus","volume":"34","author":"Cong","year":"2009","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"1-4","key":"10.1016\/j.semnephrol.2026.151723_bib0049","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.foodchem.2013.01.065","article-title":"Assay of phenolic compounds from four species of ber (Ziziphus mauritiana L.) fruits: comparison of three base hydrolysis procedure for quantification of total phenolic acids","volume":"139","author":"Memon","year":"2013","journal-title":"Food Chem"},{"issue":"20","key":"10.1016\/j.semnephrol.2026.151723_bib0050","doi-asserted-by":"crossref","first-page":"25701","DOI":"10.1007\/s13399-023-04617-8","article-title":"Identification and quantification of flavonoids in leafy by-products of Chinese jujube: comparison between young and old leaves","volume":"14","author":"Gao","year":"2024","journal-title":"Biomass Convers Biorefin"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.111017","article-title":"Myricetin: a review of the most recent research","volume":"134","author":"Song","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0052","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3177\/jnsv.52.149","article-title":"Inhibition of alpha-glucosidase and alpha-amylase by flavonoids","volume":"52","author":"Tadera","year":"2006","journal-title":"J Nutr Sci Vitaminol (Tokyo)"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151723_bib0053","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s10068-015-0249-y","article-title":"\u0391-glucosidase inhibitory activities of myricetin in animal models of diabetes mellitus","volume":"24","author":"Kang","year":"2015","journal-title":"Food Sci Biotechnol"},{"issue":"14","key":"10.1016\/j.semnephrol.2026.151723_bib0054","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1016\/S0024-3205(00)00758-X","article-title":"Effects of myricetin on glycemia and glycogen metabolism in diabetic rats","volume":"67","author":"Ong","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0055","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2174\/1874091X01206010066","article-title":"Myricetin inhibits islet amyloid polypeptide (IAPP) aggregation and rescues living mammalian cells from IAPP toxicity","volume":"6","author":"Zelus","year":"2012","journal-title":"Open Biochem J"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151723_bib0056","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1080\/09168451.2016.1171697","article-title":"Anti-inflammatory activity of myricetin from Diospyros lotus through suppression of NF-\u03baB and STAT1 activation and Nrf2-mediated HO-1 induction in lipopolysaccharide-stimulated RAW264.7 macrophages","volume":"80","author":"Cho","year":"2016","journal-title":"Biosci Biotechnol Biochem"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0057","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4239\/wjd.v15.i1.105","article-title":"Myricetin induces M2 macrophage polarization to alleviate renal tubulointerstitial fibrosis in diabetic nephropathy via PI3K\/Akt pathway","volume":"15","author":"Xu","year":"2024","journal-title":"World J Diabetes"},{"issue":"16","key":"10.1016\/j.semnephrol.2026.151723_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e35234","article-title":"Myricetin alleviates renal tubular epithelial-mesenchymal transition via NOX4\/NF-\u03baB\/Snail axis in diabetic nephropathy based on network pharmacology analysis","volume":"10","author":"Yuan","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0059","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.669642","article-title":"Myricetin inhibits SARS-CoV-2 viral replication by targeting m(pro) and ameliorates pulmonary inflammation","volume":"12","author":"Xiao","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0060","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3389\/fphar.2019.01678","article-title":"Myricetin, the main flavonoid in Syzygium cumini leaf, is a novel inhibitor of platelet thiol isomerases PDI and ERP5","volume":"10","author":"Gaspar","year":"2019","journal-title":"Front Pharmacol"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151723_bib0061","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1002\/cbic.201000790","article-title":"Myricetin: a naturally occurring regulator of metal-induced amyloid-\u03b2 aggregation and neurotoxicity","volume":"12","author":"DeToma","year":"2011","journal-title":"Chembiochem"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0062","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12906-020-02965-w","article-title":"Myricetin induces apoptosis and autophagy by inhibiting PI3K\/Akt\/mTOR signalling in human colon cancer cells","volume":"20","author":"Zhu","year":"2020","journal-title":"BMC Complement Med Ther"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0063","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijbiomac.2015.10.004","article-title":"Identification and characterization of a cytotoxic polysaccharide from the flower of Abelmoschus manihot","volume":"82","author":"Zheng","year":"2016","journal-title":"Int J Biol Macromol"},{"issue":"Pt 3","key":"10.1016\/j.semnephrol.2026.151723_bib0064","article-title":"Abelmoschi corolla polysaccharides and related metabolite ameliorates colitis via modulating gut microbiota and regulating the FXR\/STAT3 signaling pathway","volume":"277","author":"He","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157545","article-title":"Multidimensional immunomodulation by abelmoschi corolla polysaccharide: gut barrier restoration, microbiota remodelling, and systemic metabolic regulation","volume":"149","author":"Zhang","year":"2025","journal-title":"Phytomedicine"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151723_bib0066","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.3390\/molecules26071864","article-title":"Comparison of multiple bioactive constituents in the corolla and other parts of Abelmoschus manihot","volume":"26","author":"Yin","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0067","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106631","article-title":"L-arginine supplementation to mitigate cardiovascular effects of walking outside in the context of traffic-related air pollution in participants with elevated blood pressure: a randomized, double-blind, placebo-controlled trial","volume":"156","author":"Li","year":"2021","journal-title":"Environ Int"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0068","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.jep.2013.05.009","article-title":"Abelmoschi corolla non-flavonoid components altered the pharmacokinetic profile of its flavonoids in rat","volume":"148","author":"Lu","year":"2013","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0069","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jchromb.2015.10.021","article-title":"Comparative characterization of nucleotides, nucleosides and nucleobases in Abelmoschus manihot roots, stems, leaves and flowers during different growth periods by UPLC-TQ-MS\/MS","volume":"1006","author":"Du","year":"2015","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"issue":"19","key":"10.1016\/j.semnephrol.2026.151723_bib0070","first-page":"1597","article-title":"Studies on chemical constituents in flower of Abelmoschus manihot","volume":"31","author":"Lai","year":"2006","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151723_bib0071","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.3390\/foods13111754","article-title":"Phytosterols: physiological functions and potential application","volume":"13","author":"Shen","year":"2024","journal-title":"Foods"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0072","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.14233\/ajchem.2015.18924","article-title":"Analysis of volatile constituents from Abelmoschus manihot by GC-MS","volume":"27","author":"Wang","year":"2015","journal-title":"Asian J Chem"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0073","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3109\/13880209.2015.1068337","article-title":"Conjugated metabolites represent the major circulating forms of Abelmoschus manihot in vivo and show an altered pharmacokinetic profile in renal pathology","volume":"54","author":"Guo","year":"2016","journal-title":"Pharm Biol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0074","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2025.117039","article-title":"Quantification of gossypetin, myricetin, quercetin and isorhamnetin in mouse plasma: pharmacokinetic profiling after oral administration of total flavone of abelmoschi corolla","volume":"265","author":"Chen","year":"2025","journal-title":"J Pharm Biomed Anal"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0075","article-title":"Identification of the main flavonoids of Abelmoschus manihot (L.) Medik and their metabolites in the treatment of diabetic nephropathy","volume":"14","author":"Diao","year":"2023","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151723_bib0076","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular hyperfiltration: definitions, mechanisms and clinical implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0077","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1152\/physrev.00042.2012","article-title":"Renal autoregulation in health and disease","volume":"95","author":"Carlstr\u00f6m","year":"2015","journal-title":"Physiol Rev"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151723_bib0078","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1093\/ndt\/gfae027","article-title":"Glomerular hyperfiltration as a therapeutic target for CKD","volume":"39","author":"Kanbay","year":"2024","journal-title":"Nephrol Dial Transplant"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151723_bib0079","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2215\/CJN.03500412","article-title":"Association between albuminuria, kidney function, and inflammatory biomarker profile in CKD in CRIC","volume":"7","author":"Gupta","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0080","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.kint.2017.09.022","article-title":"The macrophage phenotype and inflammasome component NLRP3 contributes to nephrocalcinosis-related chronic kidney disease independent from IL-1-mediated tissue injury","volume":"93","author":"Anders","year":"2018","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0081","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/nrneph.2016.48","article-title":"TGF-\u03b2: the master regulator of fibrosis","volume":"12","author":"Meng","year":"2016","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0082","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev-physiol-022516-034227","article-title":"Mechanisms of renal fibrosis","volume":"80","author":"Humphreys","year":"2018","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0083","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41581-023-00775-0","article-title":"Oxidative stress and the role of redox signalling in chronic kidney disease","volume":"20","author":"Kishi","year":"2024","journal-title":"Nat Rev Nephrol"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0084","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/s41581-024-00922-1","article-title":"Insights into the mechanisms of fibrosis and progressive kidney injury","volume":"21","author":"Lamas","year":"2025","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151723_bib0085","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/ndt\/gfaa091","article-title":"Hypoxia in chronic kidney disease: towards a paradigm shift?","volume":"36","author":"Faivre","year":"2021","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0086","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/diagnostics15010021","article-title":"The gut-kidney axis in chronic kidney diseases","volume":"15","author":"Tsuji","year":"2024","journal-title":"Diagnostics (Basel)"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0087","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000345969","article-title":"Role of urea in intestinal barrier dysfunction and disruption of epithelial tight junction in chronic kidney disease","volume":"37","author":"Vaziri","year":"2013","journal-title":"Am J Nephrol"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0088","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1053\/j.jrn.2017.02.010","article-title":"The leaky gut and altered microbiome in chronic kidney disease","volume":"27","author":"Lau","year":"2017","journal-title":"J Ren Nutr"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0089","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1159\/000381990","article-title":"The gut as a source of inflammation in chronic kidney disease","volume":"130","author":"Lau","year":"2015","journal-title":"Nephron"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0090","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00044","article-title":"Exploring enterotype characteristics of chronic kidney disease stages 3-5 based on the partitioning around medoids clustering algorithm","volume":"12","author":"Sun","year":"2025","journal-title":"Integr Med Nephrol Androl"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0091","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1681\/ASN.2013080905","article-title":"The gut microbiome, kidney disease, and targeted interventions","volume":"25","author":"Ramezani","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0092","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/ndt\/gfq818","article-title":"The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression","volume":"26","author":"Meijers","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"9","key":"10.1016\/j.semnephrol.2026.151723_bib0093","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1681\/ASN.2013101062","article-title":"The uremic toxicity of indoxyl sulfate and p-cresyl sulfate: a systematic review","volume":"25","author":"Vanholder","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0094","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/ndt\/gfp592","article-title":"Free p-cresylsulphate is a predictor of mortality in patients at different stages of chronic kidney disease","volume":"25","author":"Liabeuf","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0095","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/ndt\/gfq580","article-title":"P-cresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease","volume":"26","author":"Wu","year":"2011","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0096","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/labinvest.2011.194","article-title":"Indoxyl sulfate-induced epithelial-to-mesenchymal transition and apoptosis of renal tubular cells as novel mechanisms of progression of renal disease","volume":"92","author":"Kim","year":"2012","journal-title":"Lab Invest"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151723_bib0097","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1093\/ndt\/15.11.1773","article-title":"An oral sorbent reduces overload of indoxyl sulphate and gene expression of TGF-beta1 in uraemic rat kidneys","volume":"15","author":"Miyazaki","year":"2000","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0098","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/ki.2012.448","article-title":"P-cresyl sulfate causes renal tubular cell damage by inducing oxidative stress by activation of NADPH oxidase","volume":"83","author":"Watanabe","year":"2013","journal-title":"Kidney Int"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0099","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1538-7836.2007.02540.x","article-title":"The uremic solute indoxyl sulfate induces oxidative stress in endothelial cells","volume":"5","author":"Dou","year":"2007","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0100","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151723_bib0101","doi-asserted-by":"crossref","first-page":"5354","DOI":"10.3390\/ijms23105354","article-title":"Short-chain fatty acids in chronic kidney disease: focus on inflammation and oxidative stress regulation","volume":"23","author":"Magliocca","year":"2022","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0102","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s11255-017-1689-5","article-title":"Gut microbiota and chronic kidney disease: implications for novel mechanistic insights and therapeutic strategies","volume":"50","author":"Pan","year":"2018","journal-title":"Int Urol Nephrol"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151723_bib0103","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1093\/ndt\/gfy171","article-title":"Effect of prebiotic (fructooligosaccharide) on uremic toxins of chronic kidney disease patients: a randomized controlled trial","volume":"34","author":"Ramos","year":"2019","journal-title":"Nephrol Dial Transplant"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151723_bib0104","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2014010042","article-title":"Randomized placebo-controlled EPPIC trials of AST-120 in CKD","volume":"26","author":"Schulman","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3390\/toxins10010019","article-title":"Impact of the oral adsorbent AST-120 on organ-specific accumulation of uremic toxins: LC-MS\/MS and MS imaging techniques","volume":"10","author":"Sato","year":"2017","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0106","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.676345","article-title":"Efficacy of AST-120 for patients with chronic kidney disease: a network meta-analysis of randomized controlled trials","volume":"12","author":"Su","year":"2021","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151723_bib0107","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41581-023-00694-0","article-title":"Regulated cell death pathways in kidney disease","volume":"19","author":"Sanz","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0108","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1681\/ASN.2015040405","article-title":"Necroinflammation in kidney disease","volume":"27","author":"Mulay","year":"2016","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151723_bib0109","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/ki.2011.450","article-title":"RIP1 (receptor-interacting protein kinase 1) mediates necroptosis and contributes to renal ischemia\/reperfusion injury","volume":"81","author":"Linkermann","year":"2012","journal-title":"Kidney Int"},{"issue":"29","key":"10.1016\/j.semnephrol.2026.151723_bib0110","doi-asserted-by":"crossref","first-page":"12024","DOI":"10.1073\/pnas.1305538110","article-title":"Two independent pathways of regulated necrosis mediate ischemia-reperfusion injury","volume":"110","author":"Linkermann","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0111","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.94979","article-title":"RIPK3 promotes kidney fibrosis via AKT-dependent ATP citrate lyase","volume":"3","author":"Imamura","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0112","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156729","article-title":"RIPK3-mediated necroptosis and apoptosis contributes to renal tubular cell progressive loss and chronic kidney disease progression in rats","volume":"11","author":"Zhu","year":"2016","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0113","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228385","article-title":"Angiotensin II triggers RIPK3-MLKL-mediated necroptosis by activating the FAS\/FASL signaling pathway in renal tubular cells","volume":"15","author":"Zhu","year":"2020","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151723_bib0114","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/s41581-022-00662-0","article-title":"Gasdermins and pyroptosis in the kidney","volume":"19","author":"Elias","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151723_bib0115","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1681\/ASN.2010020143","article-title":"The NLRP3 inflammasome promotes renal inflammation and contributes to CKD","volume":"21","author":"Vilaysane","year":"2010","journal-title":"J Am Soc Nephrol"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151723_bib0116","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41419-018-1023-x","article-title":"Caspase-11-mediated tubular epithelial pyroptosis underlies contrast-induced acute kidney injury","volume":"9","author":"Zhang","year":"2018","journal-title":"Cell Death Dis"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2021.167290","article-title":"Pyroptosis in kidney disease","volume":"434","author":"Wang","year":"2022","journal-title":"J Mol Biol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0118","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fendo.2019.00603","article-title":"TLR4\/NF-\u03baB signaling induces GSDMD-related pyroptosis in tubular cells in diabetic kidney disease","volume":"10","author":"Wang","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151723_bib0119","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1038\/s41418-021-00755-6","article-title":"GSDME-mediated pyroptosis promotes inflammation and fibrosis in obstructive nephropathy","volume":"28","author":"Li","year":"2021","journal-title":"Cell Death Differ"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0120","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41419-021-03431-2","article-title":"Gasdermin E deficiency attenuates acute kidney injury by inhibiting pyroptosis and inflammation","volume":"12","author":"Xia","year":"2021","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151723_bib0121","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/ncb3064","article-title":"Inactivation of the ferroptosis regulator GPX4 triggers acute renal failure in mice","volume":"16","author":"Friedmann Angeli","year":"2014","journal-title":"Nat Cell Biol"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151723_bib0122","doi-asserted-by":"crossref","first-page":"5033","DOI":"10.1172\/JCI129903","article-title":"Myo-inositol oxygenase expression profile modulates pathogenic ferroptosis in the renal proximal tubule","volume":"129","author":"Deng","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0123","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102939","article-title":"HDAC3 aberration-incurred GPX4 suppression drives renal ferroptosis and AKI-CKD progression","volume":"68","author":"Zhang","year":"2023","journal-title":"Redox Biol"},{"issue":"9","key":"10.1016\/j.semnephrol.2026.151723_bib0124","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/s41419-021-04137-1","article-title":"Liproxstatin-1 attenuates unilateral ureteral obstruction-induced renal fibrosis by inhibiting renal tubular epithelial cells ferroptosis","volume":"12","author":"Zhang","year":"2021","journal-title":"Cell Death Dis"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0125","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41420-022-00931-8","article-title":"Ferroptosis, a new target for treatment of renal injury and fibrosis in a 5\/6 nephrectomy-induced CKD rat model","volume":"8","author":"Wang","year":"2022","journal-title":"Cell Death Discov"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0126","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1172\/JCI39492","article-title":"Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice","volume":"120","author":"Hartleben","year":"2010","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0127","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1172\/JCI44771","article-title":"MTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice","volume":"121","author":"Inoki","year":"2011","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0128","doi-asserted-by":"crossref","first-page":"755","DOI":"10.2337\/db15-0473","article-title":"Impaired podocyte autophagy exacerbates proteinuria in diabetic nephropathy","volume":"65","author":"Tagawa","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0129","doi-asserted-by":"crossref","first-page":"tkac059","DOI":"10.1093\/burnst\/tkac059","article-title":"Autophagy in acute kidney injury and maladaptive kidney repair","volume":"11","author":"Xiang","year":"2023","journal-title":"Burns Trauma"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0130","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.963920","article-title":"Autophagy in renal fibrosis: protection or promotion?","volume":"13","author":"Dai","year":"2022","journal-title":"Front Pharmacol"},{"issue":"9","key":"10.1016\/j.semnephrol.2026.151723_bib0131","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1080\/15548627.2016.1190071","article-title":"ATG5-mediated autophagy deficiency in proximal tubules promotes cell cycle G2\/M arrest and renal fibrosis","volume":"12","author":"Li","year":"2016","journal-title":"Autophagy"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0132","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41419-019-1483-7","article-title":"ATG5-mediated autophagy suppresses NF-\u03baB signaling to limit epithelial inflammatory response to kidney injury","volume":"10","author":"Peng","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0133","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110949","article-title":"Contribution of TFEB-mediated autophagy to tubulointerstitial fibrosis in mice with adenine-induced chronic kidney disease","volume":"133","author":"Yuan","year":"2021","journal-title":"Biomed Pharmacother"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151723_bib0134","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41581-023-00741-w","article-title":"Kidney lipid dysmetabolism and lipid droplet accumulation in chronic kidney disease","volume":"19","author":"Mitrofanova","year":"2023","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0135","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3762","article-title":"Defective fatty acid oxidation in renal tubular epithelial cells has a key role in kidney fibrosis development","volume":"21","author":"Kang","year":"2015","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0136","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.kint.2024.02.025","article-title":"The key role of altered tubule cell lipid metabolism in kidney disease development","volume":"106","author":"Lee","year":"2024","journal-title":"Kidney Int"},{"issue":"8","key":"10.1016\/j.semnephrol.2026.151723_bib0137","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.7150\/thno.71722","article-title":"TWIST1 downregulation of PGC-1\u03b1 decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis","volume":"12","author":"Liu","year":"2022","journal-title":"Theranostics"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151723_bib0138","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/s41419-020-03199-x","article-title":"Involvement of FATP2-mediated tubular lipid metabolic reprogramming in renal fibrogenesis","volume":"11","author":"Chen","year":"2020","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151723_bib0139","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nrneph.2017.126","article-title":"CD36 in chronic kidney disease: novel insights and therapeutic opportunities","volume":"13","author":"Yang","year":"2017","journal-title":"Nat Rev Nephrol"},{"issue":"21","key":"10.1016\/j.semnephrol.2026.151723_bib0140","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.130317","article-title":"Increased lipogenesis and impaired \u03b2-oxidation predict type 2 diabetic kidney disease progression in American Indians","volume":"4","author":"Afshinnia","year":"2019","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0141","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1681\/ASN.2017030350","article-title":"Impaired \u03b2-oxidation and altered complex lipid fatty acid partitioning with advancing CKD","volume":"29","author":"Afshinnia","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0142","doi-asserted-by":"crossref","DOI":"10.1155\/2023\/3020033","article-title":"Clinical efficacy of Huangkui capsule plus methylprednisolone for immunoglobulin A nephropathy and its effect on renal function and serum inflammatory factors","volume":"2023","author":"Yuan","year":"2023","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0143","article-title":"Efficacy and safety of Abelmoschus manihot capsule combined with ACEI\/ARB on diabetic kidney disease: a systematic review and meta analysis","volume":"14","author":"Tan","year":"2023","journal-title":"Front Pharmacol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151723_bib0144","first-page":"263","article-title":"Clinical observation of alcohol extract of Abelmoschus manihot flowers in the treatment of diabetic nephropathy","volume":"15","author":"Yu","year":"1995","journal-title":"Chin J Integr Tradit West Med"},{"issue":"35","key":"10.1016\/j.semnephrol.2026.151723_bib0145","first-page":"3882","article-title":"Clinical study of Jiahua tablets in preventing contrast-induced nephropathy in patients undergoing coronary intervention","volume":"29","author":"Lin","year":"2020","journal-title":"Xian Dai Zhong Xi Yi Jie He Za Zhi"},{"issue":"04","key":"10.1016\/j.semnephrol.2026.151723_bib0146","first-page":"293","article-title":"Clinical study of Jiahua tablets as adjuvant therapy for lipid metabolism disorder in patients with diabetic nephropathy","volume":"39","author":"Chen","year":"2025","journal-title":"Mil Med Jnt Lo"},{"issue":"16","key":"10.1016\/j.semnephrol.2026.151723_bib0147","first-page":"2059","article-title":"Effect of Jiahua tablets as adjuvant therapy on serum inflammatory factors and renal function in patients with early diabetic nephropathy","volume":"42","author":"Zha","year":"2020","journal-title":"Guangxi Med J"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0148","first-page":"18","article-title":"Observation on the therapeutic effect of Jiahua tablets on contrast-induced kidney injury based on KIM-1 and MCP-1","volume":"39","author":"Niu","year":"2023","journal-title":"Shanxi J Tradit Chin Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0149","first-page":"430","article-title":"Effect of Qikui granules on microalbuminuria and disease progression in patients with early diabetic nephropathy","volume":"38","author":"Yan","year":"2018","journal-title":"Chin J Integr Tradit West Med"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0150","first-page":"29","article-title":"Clinical study on 31 cases of early diabetic nephropathy treated with Qikui granules combined with conventional Western therapy","volume":"49","author":"Huang","year":"2017","journal-title":"Jiangsu J Tradit Chin Med"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151723_bib0151","first-page":"2483","article-title":"Clinical efficacy and mechanism of Kunkui Baoshen Gao in patients with early- and middle-stage type 2 diabetic kidney disease from the perspective of inflammation and oxidative stress","volume":"19","author":"Xu","year":"2024","journal-title":"World J Integr Tradit West Med"},{"issue":"20","key":"10.1016\/j.semnephrol.2026.151723_bib0152","first-page":"64","article-title":"Clinical observation of Professor Liu Aihua treating stage IV diabetic nephropathy with Liuhuang Tangshenkang","volume":"11","author":"Lv","year":"2019","journal-title":"J Clin Tradit Chin Med"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151723_bib0153","first-page":"942","article-title":"Effect of Yukuiqing on chemokine expression in human mesangial cells induced by advanced glycation end products","volume":"22","author":"Sun","year":"2014","journal-title":"Chin J Diabetes"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151723_bib0154","first-page":"1102","article-title":"Effect of Yukuiqing on CTGF expression in human glomerular mesangial cells induced by advanced glycation end products","volume":"25","author":"Yang","year":"2010","journal-title":"Chin J Tradit Chin Med Pharm"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151723_bib0155","first-page":"578","article-title":"Effect of Huangkui extract powder on fibrosis of human renal tubular epithelial cells induced by high glucose","volume":"25","author":"Gao","year":"2024","journal-title":"Chin J Integr Tradit West Nephrol"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151723_bib0156","first-page":"573","article-title":"Effect of Huangkui extract powder on proliferation, apoptosis and cell cycle of mouse podocytes under high glucose conditions","volume":"20","author":"Yu","year":"2019","journal-title":"Chin J Integr Tradit West Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0157","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jphs.2021.02.005","article-title":"Hyperoside ameliorates diabetic nephropathy induced by STZ via targeting the miR-499-5p\/APC axis","volume":"146","author":"Zhou","year":"2021","journal-title":"J Pharmacol Sci"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151723_bib0158","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1139\/cjpp-2016-0066","article-title":"Hyperoside ameliorates glomerulosclerosis in diabetic nephropathy by downregulating miR-21","volume":"94","author":"Zhang","year":"2016","journal-title":"Can J Physiol Pharmacol"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0159","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s11418-016-1007-z","article-title":"Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury","volume":"70","author":"Zhang","year":"2016","journal-title":"J Nat Med"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0160","doi-asserted-by":"crossref","first-page":"6413","DOI":"10.1038\/s41598-017-06844-2","article-title":"Hyperoside pre-treatment prevents glomerular basement membrane damage in diabetic nephropathy by inhibiting podocyte heparanase expression","volume":"7","author":"An","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0161","article-title":"Total flavones of Abelmoschus manihot ameliorates podocyte pyroptosis and injury in high glucose conditions by targeting METTL3-dependent m(6)a modification-mediated NLRP3-inflammasome activation and PTEN\/PI3K\/Akt signaling","volume":"12","author":"Liu","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0162","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155642","article-title":"A single-cell profile reveals the transcriptional regulation responded for Abelmoschus manihot (L.) treatment in diabetic kidney disease","volume":"130","author":"Wu","year":"2024","journal-title":"Phytomedicine"},{"issue":"10","key":"10.1016\/j.semnephrol.2026.151723_bib0163","first-page":"2646","article-title":"Effects and mechanisms of total flavones of Abelmoschus manihot in improving insulin resistance and podocyte epithelial-mesenchymal transition in diabetic kidney disease based on IRS1\/PI3K\/Akt pathway","volume":"48","author":"Wang","year":"2023","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151723_bib0164","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/jmf.2011.1921","article-title":"Pretreatment with the total flavone glycosides of Flos Abelmoschus manihot and hyperoside prevents glomerular podocyte apoptosis in streptozotocin-induced diabetic nephropathy","volume":"15","author":"Zhou","year":"2012","journal-title":"J Med Food"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116150","article-title":"Huangkui capsule alleviates doxorubicin-induced proteinuria via protecting against podocyte damage and inhibiting JAK\/STAT signaling","volume":"306","author":"Zhao","year":"2023","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0166","doi-asserted-by":"crossref","first-page":"443","DOI":"10.3389\/fphar.2018.00443","article-title":"Inhibition of Akt\/mTOR\/p70S6K signaling activity with Huangkui capsule alleviates the early glomerular pathological changes in diabetic nephropathy","volume":"9","author":"Wu","year":"2018","journal-title":"Front Pharmacol"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151723_bib0167","doi-asserted-by":"crossref","first-page":"3199","DOI":"10.1002\/ar.25123","article-title":"Inhibition of ferroptosis of renal tubular cells with total flavones of Abelmoschus manihot alleviates diabetic tubulopathy","volume":"306","author":"Wang","year":"2023","journal-title":"Anat Rec (Hoboken)"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0168","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115899","article-title":"Effects of total flavones of Abelmoschus manihot (L.) on the treatment of diabetic nephropathy via the activation of solute carriers in renal tubular epithelial cells","volume":"169","author":"Yu","year":"2023","journal-title":"Biomed Pharmacother"},{"issue":"13","key":"10.1016\/j.semnephrol.2026.151723_bib0169","first-page":"3738","article-title":"Effects and mechanisms of total flavones of Abelmoschus manihot combined with empagliflozin in attenuating diabetic tubulopathy through multiple targets based on mitochondrial homeostasis and ZBP1-mediated panoptosis","volume":"50","author":"Cha","year":"2025","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151723_bib0170","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00210-011-0613-2","article-title":"In vivo antioxidative effect of isoquercitrin on cadmium-induced oxidative damage to mouse liver and kidney","volume":"383","author":"Li","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0171","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.transproceed.2019.12.038","article-title":"Isoquercitrin attenuates renal ischemia\/reperfusion injury through antioxidation, anti-inflammation, and antiapoptosis in mice","volume":"52","author":"Liang","year":"2020","journal-title":"Transplant Proc"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0172","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.599416","article-title":"Isoquercitrin ameliorates cisplatin-induced nephrotoxicity via the inhibition of apoptosis, inflammation, and oxidative stress","volume":"11","author":"Wang","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0173","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.151142","article-title":"Isoquercitrin improves diabetes nephropathy by inhibiting the sodium-glucose co-transporter-2 pathway","volume":"744","author":"Zhang","year":"2025","journal-title":"Biochem Biophys Res Commun"},{"issue":"25","key":"10.1016\/j.semnephrol.2026.151723_bib0174","article-title":"Isoquercitrin alleviates diabetic nephropathy by inhibiting STAT3 phosphorylation and dimerization","volume":"12","author":"Xuan","year":"2025","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0175","doi-asserted-by":"crossref","DOI":"10.1080\/0886022X.2024.2327495","article-title":"Quercetin improves diabetic kidney disease by inhibiting ferroptosis and regulating the Nrf2 in streptozotocin-induced diabetic rats","volume":"46","author":"Zhang","year":"2024","journal-title":"Ren Fail"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0176","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1142\/S0192415X25500715","article-title":"Quercetin alleviates folic acid-induced renal fibrosis by inhibiting tubular epithelial cell ferroptosis via EGFR\/ACSL4 pathway","volume":"53","author":"Gao","year":"2025","journal-title":"Am J Chin Med"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0177","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154975","article-title":"Huangkui capsule attenuates diabetic kidney disease through the induction of mitophagy mediated by STING1\/PINK1 signaling in tubular cells","volume":"119","author":"Zhu","year":"2023","journal-title":"Phytomedicine"},{"issue":"19","key":"10.1016\/j.semnephrol.2026.151723_bib0178","first-page":"2652","article-title":"Discussion on the mechanism of Astragalus manihot preparations in preventing contrast nephropathy based on NGAL, IL-1\u0392, and CYSC","volume":"31","author":"Liu","year":"2022","journal-title":"Mod J Integr Tradit Chin West Med"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0179","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.733808","article-title":"Hyperoside suppresses renal inflammation by regulating macrophage polarization in mice with type 2 diabetes mellitus","volume":"12","author":"Liu","year":"2021","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.semnephrol.2026.151723_bib0180","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.3390\/antiox11112238","article-title":"Quercetin ameliorates renal injury and pyroptosis in lupus nephritis through inhibiting IL-33\/ST2 pathway in vitro and in vivo","volume":"11","author":"Chen","year":"2022","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0181","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2025.104997","article-title":"Quercetin alleviates diabetic nephropathy by inhibiting M1 macrophage polarization via targeting NLRC5\/NLRP3 pathway","volume":"414","author":"Abudoureyimu","year":"2025","journal-title":"Cell Immunol"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0182","article-title":"Quercetin and allopurinol ameliorate kidney injury in STZ-treated rats with regulation of renal NLRP3 inflammasome activation and lipid accumulation","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0183","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.phymed.2018.01.026","article-title":"Kidney protection effects of dihydroquercetin on diabetic nephropathy through suppressing ROS and NLRP3 inflammasome","volume":"41","author":"Ding","year":"2018","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0184","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.bcp.2018.05.007","article-title":"Quercetin ameliorates kidney injury and fibrosis by modulating M1\/M2 macrophage polarization","volume":"154","author":"Lu","year":"2018","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151723_bib0185","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1007\/s00011-023-01730-2","article-title":"Quercetin alleviates tubulointerstitial inflammation by inhibiting exosomes-mediated crosstalk between tubular epithelial cells and macrophages","volume":"72","author":"Yin","year":"2023","journal-title":"Inflamm Res"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0186","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3389\/fphar.2019.00647","article-title":"Myricetin attenuated diabetes-associated kidney injuries and dysfunction via regulating nuclear factor (erythroid derived 2)-like 2 and nuclear factor-\u03baB signaling","volume":"10","author":"Yang","year":"2019","journal-title":"Front Pharmacol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0187","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/13880209.2017.1412467","article-title":"Total flavones of Abelmoschus manihot improve diabetic nephropathy by inhibiting the iRhom2\/TACE signalling pathway activity in rats","volume":"56","author":"Liu","year":"2017","journal-title":"Pharm Biol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0188","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.566611","article-title":"Total flavones of Abelmoschus manihot remodels gut microbiota and inhibits microinflammation in chronic renal failure progression by targeting autophagy-mediated macrophage polarization","volume":"11","author":"Tu","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0189","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.phymed.2018.12.021","article-title":"Huangkui capsule alleviates renal tubular epithelial-mesenchymal transition in diabetic nephropathy via inhibiting NLRP3 inflammasome activation and TLR4\/NF-\u03baB signaling","volume":"57","author":"Han","year":"2019","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0190","first-page":"486","article-title":"Hyperoside protects human kidney\u20112 cells against oxidative damage induced by oxalic acid","volume":"18","author":"Chen","year":"2018","journal-title":"Mol Med Rep"},{"issue":"7","key":"10.1016\/j.semnephrol.2026.151723_bib0191","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1080\/10715762.2019.1623883","article-title":"Protective effect of hyperoside against renal ischemia-reperfusion injury via modulating mitochondrial fission, oxidative stress, and apoptosis","volume":"53","author":"Wu","year":"2019","journal-title":"Free Radic Res"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0192","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175289","article-title":"Rutin and selenium nanoparticles protected against STZ-induced diabetic nephropathy in rats through downregulating JAK-2\/STAT3 pathway and upregulating Nrf-2\/HO-1 pathway","volume":"933","author":"Zaghloul","year":"2022","journal-title":"Eur J Pharmacol"},{"issue":"1-2","key":"10.1016\/j.semnephrol.2026.151723_bib0193","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11010-020-03758-y","article-title":"Rutin ameliorates metabolic acidosis and fibrosis in alloxan induced diabetic nephropathy and cardiomyopathy in experimental rats","volume":"471","author":"Ganesan","year":"2020","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.semnephrol.2026.151723_bib0194","first-page":"597","article-title":"Protective effects of rutin on kidney in type 1 diabetic mice","volume":"33","author":"Gong","year":"2020","journal-title":"Pak J Pharm Sci"},{"issue":"19-20","key":"10.1016\/j.semnephrol.2026.151723_bib0195","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.lfs.2012.09.003","article-title":"Preventive effects of rutin on the development of experimental diabetic nephropathy in rats","volume":"91","author":"Hao","year":"2012","journal-title":"Life Sci"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0196","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1535352","article-title":"Huangkui capsules regulate tryptophan metabolism to improve diabetic nephropathy through the KEAP1\/Nrf2\/HO-1 pathway","volume":"16","author":"Su","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0197","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.jep.2016.05.033","article-title":"Huangkui capsule, an extract from Abelmoschus manihot (L.) Medic, improves diabetic nephropathy via activating peroxisome proliferator-activated receptor (PPAR)-\u03b1\/\u03b3 and attenuating endoplasmic reticulum stress in rats","volume":"189","author":"Ge","year":"2016","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0198","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1039\/C9FO00373H","article-title":"Quercetin inhibits kidney fibrosis and the epithelial to mesenchymal transition of the renal tubular system involving suppression of the Sonic Hedgehog signaling pathway","volume":"10","author":"Liu","year":"2019","journal-title":"Food Funct"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0199","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1097\/IMNA-D-24-00051","article-title":"Therapeutic effects of quercetin on renal fibrosis and injury","volume":"12","author":"Wang","year":"2025","journal-title":"Integr Med Nephrol Androl"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0200","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ptr.7599","article-title":"Quercetin inhibits the amphiregulin\/EGFR signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in obstructive nephropathy","volume":"37","author":"Wang","year":"2023","journal-title":"Phytother Res"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0201","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2026.103349","article-title":"Iron-quercetin complex ameliorates chronic kidney disease via inhibiting the renal TGF-\u03b21\/SMAD3\/EGR1 axis-mediated kidney injury and fibrosis","volume":"100","author":"Li","year":"2026","journal-title":"Tissue Cell"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0202","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.intimp.2016.03.029","article-title":"Rutin ameliorates kidney interstitial fibrosis in rats with obstructive nephropathy","volume":"35","author":"Wang","year":"2016","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0203","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154700","article-title":"Rutin alleviates EndMT by restoring autophagy through inhibiting HDAC1 via PI3K\/Akt\/mTOR pathway in diabetic kidney disease","volume":"112","author":"Dong","year":"2023","journal-title":"Phytomedicine"},{"issue":"14","key":"10.1016\/j.semnephrol.2026.151723_bib0204","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1055\/s-0042-110859","article-title":"Rutin prevents high glucose-induced renal glomerular endothelial hyperpermeability by inhibiting the ROS\/RHOA\/ROCK signaling pathway","volume":"82","author":"Wang","year":"2016","journal-title":"Planta Med"},{"issue":"5","key":"10.1016\/j.semnephrol.2026.151723_bib0205","first-page":"4725","article-title":"Rutin ameliorates renal fibrosis and proteinuria in 5\/6-nephrectomized rats by anti-oxidation and inhibiting activation of TGF\u03b21-Smad signaling","volume":"8","author":"Han","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0206","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116208","article-title":"Targeting ROCK1 in diabetic kidney disease: unraveling mesangial fibrosis mechanisms and introducing myricetin as a novel antagonist","volume":"171","author":"Yuan","year":"2024","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0207","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.113548","article-title":"Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho\/TGF-\u03b21\/p38MAPK signaling pathway","volume":"281","author":"Gu","year":"2021","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0208","doi-asserted-by":"crossref","first-page":"996","DOI":"10.3389\/fphar.2020.00996","article-title":"Huangkui capsule ameliorates renal fibrosis in a unilateral ureteral obstruction mouse model through TRPC6 dependent signaling pathways","volume":"11","author":"Gu","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0209","doi-asserted-by":"crossref","DOI":"10.6061\/clinics\/2021\/e2904","article-title":"Huangkui capsule in combination with leflunomide improves immunoglobulin A nephropathy by inhibiting the TGF-\u03b21\/SMAD3 signaling pathway","volume":"76","author":"Pei","year":"2021","journal-title":"Clinics (Sao Paulo)"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0210","doi-asserted-by":"crossref","DOI":"10.1097\/IMNA-D-24-00040","article-title":"Qi-Huang-Yi-Shen formula alleviate tubular epithelial-mesenchymal tTransition in diabetic kidney disease through HIF-1a\/snail signaling pathway","volume":"12","author":"Yang","year":"2025","journal-title":"Integr Med Nephrol Androl"},{"issue":"12","key":"10.1016\/j.semnephrol.2026.151723_bib0211","doi-asserted-by":"crossref","first-page":"4197","DOI":"10.18632\/aging.101723","article-title":"Hyperoside attenuates renal aging and injury induced by D-galactose via inhibiting AMPK-ULK1 signaling-mediated autophagy","volume":"10","author":"Liu","year":"2018","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0212","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ebiom.2019.08.069","article-title":"Senolytics decrease senescent cells in humans: preliminary report from a clinical trial of dasatinib plus quercetin in individuals with diabetic kidney disease","volume":"47","author":"Hickson","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0213","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155705","article-title":"Senolytic combination of dasatinib and quercetin attenuates renal damage in diabetic kidney disease","volume":"130","author":"Guo","year":"2024","journal-title":"Phytomedicine"},{"issue":"3","key":"10.1016\/j.semnephrol.2026.151723_bib0214","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3892\/ijmm.2024.5350","article-title":"Senolytic combination of dasatinib and quercetin protects against diabetic kidney disease by activating autophagy to alleviate podocyte dedifferentiation via the notch pathway","volume":"53","author":"Zhu","year":"2024","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2026.106124","article-title":"Senolytics, dasatanib plus quercetin, reduce kidney inflammation, senescent cell abundance, and injury while restoring geroprotective factors in murine diabetic kidney disease","volume":"124","author":"Bian","year":"2026","journal-title":"EBioMedicine"},{"issue":"Pt A","key":"10.1016\/j.semnephrol.2026.151723_bib0216","article-title":"Mechanistic insights into myricetin-regulated autophagy via the PI3K\/Akt and PINK1\/Parkin pathway in diabetic kidney disease treatment","volume":"355","author":"Liu","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0217","article-title":"Total flavonoids from Abelmoschus manihot (L.) improve diabetes nephropathy by regulating the gut-kidney axis","volume":"12","author":"Yu","year":"2025","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0218","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1424968","article-title":"Effects of Abelmoschus manihot (L.) and its combination with irbesartan in the treatment of diabetic nephropathy via the gut-kidney axis","volume":"15","author":"Yu","year":"2024","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.semnephrol.2026.151723_bib0219","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1111\/1751-7915.14200","article-title":"Abelmoschus manihot ameliorates the levels of circulating metabolites in diabetic nephropathy by modulating gut microbiota in non-obese diabetes mice","volume":"16","author":"Shi","year":"2023","journal-title":"Microb Biotechnol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.119197","article-title":"Broad range lipidomics and metabolomics coupled with 16s rRNA sequencing to reveal the mechanisms of Huangkui capsule against cisplatin-induced nephrotoxicity","volume":"340","author":"Liao","year":"2025","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0221","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2026.121196","article-title":"Integrated metabolomics and proteomics analysis elucidated the therapeutic effect of Huangkui capsule on tacrolimus-induced chronic nephrotoxicity in rats","volume":"360","author":"Pang","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0222","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156801","article-title":"Quercetin ameliorates hyperuricemic nephropathy through improving gut dysfunctions and decreasing gut bacteria-derived uremic toxins","volume":"143","author":"Peng","year":"2025","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0223","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/19490976.2020.1823800","article-title":"Targeting the gut microbial metabolic pathway with small molecules decreases uremic toxin production","volume":"12","author":"Wang","year":"2020","journal-title":"Gut Microbes"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0224","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.157213","article-title":"Quercetin ameliorates renal injury by promoting UCP1-mediated alleviation of lipid accumulation in diabetic kidney disease","volume":"147","author":"Yong","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.semnephrol.2026.151723_bib0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejphar.2014.09.014","article-title":"Renoprotective effect of myricetin restrains dyslipidemia and renal mesangial cell proliferation by the suppression of sterol regulatory element binding proteins in an experimental model of diabetic nephropathy","volume":"743","author":"Kandasamy","year":"2014","journal-title":"Eur J Pharmacol"},{"issue":"6","key":"10.1016\/j.semnephrol.2026.151723_bib0226","first-page":"493","article-title":"Efficacy of Huangkui capsules in IgA nephropathy and analysis of influencing factors","volume":"26","author":"Xing","year":"2025","journal-title":"Chin J Integr Tradit West Nephrol"},{"issue":"1","key":"10.1016\/j.semnephrol.2026.151723_bib0227","first-page":"88","article-title":"Clinical efficacy of Huangkui capsules in the treatment of targeted drug-related proteinuria in patients with hepatocellular carcinoma","volume":"33","author":"Li","year":"2026","journal-title":"Chin J Clin Med"},{"key":"10.1016\/j.semnephrol.2026.151723_bib228","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.774414","article-title":"New insights into the effects of individual Chinese herbal medicines on chronic kidney disease","volume":"12","author":"Shao","year":"2021","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.semnephrol.2026.151723_bib229","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1709530","article-title":"Therapeutic potential of Abelmoschus manihot: mechanisms of action and clinical use in traditional Chinese medicine formulas","volume":"16","author":"Xue","year":"2025","journal-title":"Front Pharmacol"}],"container-title":["Seminars in Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929526000422?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0270929526000422?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:51:28Z","timestamp":1791316288000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0270929526000422"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":229,"alternative-id":["S0270929526000422"],"URL":"https:\/\/doi.org\/10.1016\/j.semnephrol.2026.151723","relation":{},"ISSN":["0270-9295"],"issn-type":[{"value":"0270-9295","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Abelmoschus manihot in Chronic Kidney Disease: Evidence-Based Therapeutics and Mechanistic Insights","name":"articletitle","label":"Article Title"},{"value":"Seminars in Nephrology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semnephrol.2026.151723","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"151723"}}